Q4 2025 earnings call recap: clonoSEQ MRD growth, 2026 revenue guidance, margins, cash burn and risks—read now.

Incentive-driven volume, fragile security design, and state pushback could test prediction markets in 2026, according to a ...

Analysts rate the stock a Buy, with a mean price target of $354.95—about 15% below Saia’s current share price of $415.46. That disconnect underscores the market’s challenge: Saia shares have surged ...

Polymarket partners with Kaito AI to launch attention markets, letting users trade on social media mindshare and public sentiment trends.

Patterns created using advanced fault models provide higher test coverage, improved defect detection, and higher-yielding ...

Analysts expect earnings of 84 cents a share on revenue of $5.52 billion for the quarter ended December 2025. That represents a sharp sequential increase from the 19 cents per share reported in the ...

NordVPN Stopped Most Phishing Emails in Third-Party Testing, Study Says ...

A record-setting volume of the white stuff hit Milton in late January and has consistently kept snow removal crews busy and ...

The Coca-Cola Company KO has been witnessing lower volumes across its key markets, reflecting persistent consumer strain and weaker category trends. Despite this, the company is focused on delivering ...

Does the Mercury/Solis pairing tick all the boxes?

Tolebrutinib failed to lower disability progression risk in primary progressive MS in a Phase 3 trial, with data shown at ...

We've tried to keep things reasonably upbeat this time around, in a bid to stop those SAD symptoms from surfacing. So if ...